# Tumor Feeding Vessels Deprivation Combined With Tyrosine Kinase Inhibitor in Liver Transplantation

> **NCT05448339** · — · COMPLETED · sponsor: **Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 197 (actual)

## Conditions studied

- Liver Transplantation

## Interventions

- **COMBINATION_PRODUCT:** PVHA or TACE

## Key facts

- **NCT ID:** NCT05448339
- **Lead sponsor:** Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-01-01
- **Target enrollment:** 197 (ACTUAL)
- **Last updated:** 2024-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05448339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05448339, "Tumor Feeding Vessels Deprivation Combined With Tyrosine Kinase Inhibitor in Liver Transplantation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05448339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*